“California is working urgently across all levels of government to slow the spread of monkeypox, leveraging our robust testing, contact tracing and strengthened community partnerships during the pandemic to ensure our focus on vaccines, treatment and awareness is most at risk,” Governor Newsom said. “We will continue to work with the federal government to secure more vaccinations, raise awareness about reducing risks, and stand by the LGBTQ community in the fight against stigma.”
To expand vaccination efforts, the announcement enables Emergency Medical Services (EMS) personnel to administer monkeypox vaccines that have been approved by the Food and Drug Administration, similar to the recently enacted legal mandate for pharmacists to administer the vaccines. The country’s response to monkeypox relies on the infrastructure developed during the COVID-19 pandemic to deploy vaccine clinics and ensure comprehensive and targeted outreach in partnership with local and community organizations.
A copy of the emergency declaration can be found here.
Last month, California public health leaders urged federal partners to make more doses of the vaccine available to the state as quickly as possible so the state can expand eligibility for both confirmed and probable exposures, as well as for individuals at high risk of contracting the infection. virus. So far, the state has distributed more than 25,000 vaccine doses and will make additional allocations in the coming days and weeks. Los Angeles County received a separate allocation for the vaccine. In all, the state has received more than 61,000 doses. The state is also supporting mass vaccination efforts in collaboration with local residents, including helping to provide staff and mobile clinics. The state allocates doses to local health departments based on a number of factors, including the number of monkeypox cases reported in the area and an estimate of the population at risk.
As of July 28, the state has expanded its testing capacity to process more than 1,000 tests per week. State public health laboratory leaders work with local public health, academic and commercial laboratories to ensure that testing capacity is increasingly available and coordinated with the public health response. CDPH is also expanding treatment options. Access to the antiviral drug tecovirimat (TPOXX) used to treat monkeypox is limited, but treatment can now be offered at more than 30 facilities and providers across the state.
The state continues outreach and education efforts to inform Californians about monkeypox and ways to limit its spread. The state has hosted many webinars for local health departments, community organizations, and other health care providers, and has attended many town halls and community meetings to speak with and listen to the public and local leaders. CDPH also schedules hearings with the LGBTQ community. CDPH is currently running paid advertising campaigns on several digital media platforms to raise awareness and engage communities at greater risk of monkeypox.